Lexicon Pharmaceuticals (LXRX)
(Delayed Data from NSDQ)
$1.07 USD
0.00 (0.00%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.07 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Lexicon Pharmaceuticals, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Biomedical and Genetics industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
LXRX 1.07 0.00(0.00%)
Will LXRX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LXRX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LXRX
Alnylam Wins EC Nod for Label Expansion of Amvuttra for ATTR-CM
KURA Stock Rises More Than 15% This Past Week: Here's Why
LXRX: What are Zacks experts saying now?
Zacks Private Portfolio Services
TPST Stock Up on EMA's Orphan Drug Tag for Liver Cancer Therapy
Zoetis Stock Rises 13% in a Month: Time to Add to Your Portfolio?
Lyra Stock Soars 356% in a Week on Strong Rhinosinusitis Study Success
Other News for LXRX
Lexicon (LXRX) Regains Compliance with Nasdaq's Minimum Bid Rule
Lexicon Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement | LXRX ...
Lexicon regains compliance with Nasdaq minimum bid price requirement
Lexicon Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025 | ...
Largest borrow rate increases among liquid names